Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million, sources sayCNBC • 01/14/21
Accolade Inc.: Bullish Outlook As Its HealthTech Platform Helps Companies SaveSeeking Alpha • 01/12/21
Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 01/08/21
Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/20/20
Accolade to Participate in the 29th Annual Credit Suisse Healthcare ConferenceGlobeNewsWire • 10/28/20
Accolade Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 10/26/20
Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/15/20
Health benefits tech company Accolade sees revenue rise 24% to $36.8M in Q3, but stock dipsGeekWire • 10/14/20
Accolade adds mental health support through Ginger partnership, citing growing crisisGeekWire • 09/17/20
Accolade to Participate in the Morgan Stanley 18th Annual Healthcare ConferenceGlobeNewsWire • 09/01/20
Accolade's (ACCD) CEO Rajeev Singh on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/14/20
Health tech company Accolade boosts revenue 25% in first report since IPO, as COVID-19 roils industryGeekWire • 08/14/20
Accolade Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesPRNewsWire • 07/07/20
Accolade CEO Raj Singh on health tech company’s IPO, path to profits, and the pandemic’s ‘second hit’GeekWire • 07/06/20